Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Interventional × IMM-101 × Clear all

Phase

Status

Sponsor Class

INDUSTRY 5 OTHER 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 COVID-19 1

Interventions

Radiotherapy 268 Cisplatin 243 Cyclophosphamide 200 Doxorubicin 156 Paclitaxel 152 Carboplatin 138 Vincristine 136 Etoposide 123 Filgrastim 120 Fluorouracil 106 Gemcitabine 104 Docetaxel 100 Dexamethasone 94 Methotrexate 92 Cytarabine 91 Leucovorin 80 Prednisone 77 Granulocyte Colony-Stimulating Factor 64 Capecitabine 58 Irinotecan 54 Specimen Handling 51 Magnetic Resonance Spectroscopy 51 Ifosfamide 49 Radiation 48 Oxaliplatin 47 Temozolomide 44 Radiotherapy, Conformal 43 Platinum 42 Peripheral Blood Stem Cell Transplantation 41 Daunorubicin 41

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04442048 2025-12-30

COV-IMMUNO

Canadian Cancer Trials Group

Phase 3 Completed

COVID-19, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡